Tuesday, March 18, 2014

Lawsuits, Federal scrutiny mount for GM over ignition switch recall.

Reuters reports on motorist outrage at the notion that GM sat on information concerning a faulty ignition switch in its cars for years without informing regulators. The article details the experiences of several drivers of affected cars, some of whom have posted complaints on the website arfc.org, which sends information to NHTSA. The article notes the ongoing NHTSA probe as well as the Administration’s description of the faulty switch that could get shifted from the “on” position to the “accessory” position. The article also references plaintiffs’ attorneys from civil litigation who scoff at GM’s offer of a $500 credit towards the purchase or lease of a new car for affected drivers.

The Detroit Free Press reports that a lawsuit has been filed stemming from a 2006 crash in Wisconsin that killed two teenage girls who were driving in a 2005 Chevrolet Cobalt, one of the vehicles affected by the recall. The suit is also being filed “on behalf of anyone who has bought or leased a vehicle suspected of having a faulty ignition switch” and seeks compensation for the decrease in resale value for the affected vehicles. Plaintiffs allege that the accident in question was not related to alcohol use but was rather affected by the shutting down of power systems caused by the malfunctioning switch. The article notes that the lawsuit “could be the first test of GM’s legal immunity from liability for deaths or injuries in accidents that happened before the current company was created” following the 2009 bankruptcy. The article notes that GM documents filed with NHTSA “show the company knew of a problem with ignition switches on early Saturn Ions as early as 2001.”

The New York Times reports that Canadian politicians are looking into how national transportation officials handled the information they had on the ignition switch issue. Transport Canada had recently announced “that it would investigate the links between General Motors’ ignition-switch defects and a fatal crash last June.” The article notes that 236,000 of the recalled vehicles across six models are in Canada. The accident from June 2013 occurred in Quebec and involved a “high-severity motor-vehicle collision when the vehicle went off road and impacted multiple trees,” killing the driver who was not wearing a seatbelt at the time.

USA Today reports that Transport Canada is analyzing black box data from the vehicle, identified as a 2007 Chevrolet Cavalier. The last known fatality to have been linked to the defect was in 2009, while the article notes that GM mechanics noticed the issue in 2004 while testing the 2005 Chevy Cobalt. The article also points out that NHTSA’s fine for GM could be as high as $35 million, while the Department of Justice is said to be examining the possibility for criminal charges.

Bloomberg News reports that the recall, which was only doubled to include 1.6 million vehicles on February 25, has “clouded the reputation of the biggest U.S. automaker ... and raised a question that investigators in Washington, New York and inside GM are pursuing in parallel: Why didn’t GM recognize the potential dangers sooner?” NHTSA Spokesman Nathan Naylor reportedly explained that NHTSA “didn’t force GM to conduct the recall sooner because GM hadn’t provided timely information about the connection between defective ignition switches and failing air bags.” The article discusses at length a wrongful death lawsuit being pressed by Georgia plaintiffs stemming from a 2010 crash. The article includes a statement from GM Spokesperson Greg Martin acknowledging that the company’s decision-making process “was not as robust as it should have been.”

The Automotive News reports on a fatal 2009 crash in Pennsylvania in which a 2005 Cobalt’s airbags failed to deploy, with NHTSA investigators unable to provide a connection to the ignition switch issue at the time. The article provides a timeline of the events in the case, including a related 2005 service bulletin that GM had sent out. The article also notes that GM must provide “reams” of information to House and Senate committees by March 25 and must address the 107-question list from NHTSA by April 3. One industry analyst compares the crisis for GM to the infamous Ford Pinto episode, and the article suggests that the $100 million in repair costs could pale in comparison to results from the wave of litigation and potential government fines.

GM retains two law firms to investigate how company handled ignition switch defect. Under the headline “General Motors Calls The Lawyers,” the New York Times reports at length on GM’s choice to retain law firms King & Spalding and Jenner & Block, to proceed with a thorough “investigation into why the company failed for more than a decade to alert regulators and consumers to the defect.” According to the report, “hiring outside counsel in these cases is part investigation, part public-relations gambit and part legal strategy.” The report notes that the company’s decision to retain the two firms happened “just days after” NHTSA sent GM “a detailed order” demanding answers to “107 specific questions related to the defect and the company’s handling of it.”

The Los Angeles Times reports that GM “has acknowledged to the National Highway Traffic Safety Administration that at least 12 deaths and 31 traffic accidents have been linked to its vehicles’ faulty ignition switches.”

GM customers file class action suits.

TIME reports that a class action suit representing “customers claiming their vehicles lost value because of serious safety problems with General Motors vehicles” was filed on Friday, and will probably be just “the first of many.” The suit says that “GM’s mishandling of the ignition switch defect....has adversely affected the company’s reputation as a manufacturer of safe, reliable vehicles with high resale value.”

Bloomberg News reports that attorney Bob Hillard and other lawyers filed for a class-action suit against GM yesterday in Federal court in Corpus Christi, Texas, seeking “to recover $6 billion to $10 billion for the lost value of cars affected by the recall.” As for the fact that GM’s bankruptcy makes it no longer liable for accidents that happened before it sought bankruptcy protection, Hillard comments that “I’m going to go back to that bankruptcy judge and say, ‘You have to undo this, the liability of old GM, because it was the new GM’s continued coverup after the bankruptcy that allowed people to be hurt or killed.’” According to Bingham Greenebaum Doll LLP bankruptcy attorney Chip Bowles, however, “A few bankruptcy cases have been set aside for fraud on the court, but you have to establish deliberate fraud and concealment.”

The CBS Evening News broadcast briefly on the suit, while the Detroit Free Press also reports.

NHTSA reaffirms there was not enough evidence to warrant investigating GM. In continuing coverage of the General Motors recall of 1.6 million vehicles, most outlets are focusing on NHTSA’s and the company’s responses to highly vocal criticism. Several national outlets, such as ABC News, USA Today, Time, and CNN’s Money, are picking up the story that first appeared in the New York Times on a study by the Center for Auto Safety that counted 303 deaths in crashes involving the same type of GM vehicles that have been recalled. The CAS study further implied that NHTSA should have acted more swiftly to open a recall investigation.

The website of GMAuthority reports with continuing coverage of Secretary Foxx’s testimony to the Senate Appropriations Committee on Thursday. Foxx claimed that “Over the last decade there were complaints related to (these) particular vehicle(s), and despite three crash investigations and other research, the data was inconclusive. It just didn’t point to a formal investigation.” The report also notes that “Foxx said the NHTSA launched three crash investigations between 2004-2006, with two of those having their ignition switched moved from ‘run’ to ‘accessory,’ which may have disabled the air bags,” although “three people perished in those two accidents.”

WXYZ-TV Detroit reports from its website that Foxx added, “NHTSA is currently looking for ways to improve its own investigations and recall processes.”

ABC News reports online that the Center for Auto Safety conducted a review of Federal crash data and found that “303 people died after airbags failed to deploy in two of the General Motors car brands that were recalled last month.” GM dismissed the findings as being overly simplified, and, likewise, the report notes that NHTSA is claiming that “there was still not enough evidence to require a formal investigation into airbag defects.”

USA Today reports from its website, saying that the NYTimes noted that Friedman Research, the group commissioned by the Center for Auto Safety to go through the Fatality Analysis Reporting System, “looked for non-rear impact crashes in which the bags did not deploy.” USA Today conducted its own analysis of NHTSA files, though, and found that the agency’s records “show only 87 complaints involving the recalled GM vehicles in the ‘stall’ category,” and there were “no deaths are among those.”

TIME reports that on Thursday the Center for Auto Safety stated in a letter that “NHTSA could and should have initiated a defect investigation to determine why airbags were not deploying in Cobalts and Ions in increasing numbers.” GM spokesperson Greg Martin responded, however, to the NYTimes story, saying that “without rigorous analysis, it is pure speculation to attempt to draw any meaningful conclusions.”

For its part, the Detroit Free Press notes that “death counts can be misleading in the midst of a recall,” citing the case of Toyota’s sudden acceleration recall where a government probe later uncovered that “only five deaths were tied to unexpected acceleration in Toyota and Lexus vehicles.” The report also says that NHTSA reiterated, “When NHTSA finds a trend that indicates a vehicle may be an outlier, we take action.”
The Detroit Bureau reports that former NHTSA Administrator Joan Claybrook “said the current threshold for ordering an investigation is too tough and officials don’t seem to understand that it should be much lower.” Additionally, CAS Executive Director Clarence Ditlow says that GM should have been more proactive as well, because “the whole point of the recall is to eliminate the product liability lawsuit, which causes quite a bit of damage to (an automaker’s) brand as well as costing a lot of money in damages.”


We believe that obtaining legal satisfaction from those who harmed you shouldn’t require more hardship. That’s why we do everything we can to streamline the process, and we will file a lawsuit on your behalf if necessary. If you or a loved one has been affected by this recall, and you believe it caused an injury, contact Chhabra & Gibbs today by going to our website at www.cglawms.com or calling this number: 601-948-8005.

Monday, March 17, 2014

GM Recall

On Feb. 13, 2014, General Motors (GM) recalled 780,000 Chevrolet Cobalts and certain Pontiac vehicles to repair an ignition switch problem that can allow the key to unintentionally slip from its “run” position when the car hits a bump or if the keychain is too heavy. As a result, the defect can cause an engine shutdown and loss of power steering, brakes, and safety systems, including its airbags and anti-lock brakes.

On Feb. 25, GM expanded the recall to include hundreds of thousands of additional Chevy, Pontiac, and Saturn cars, bringing the total number of affected vehicles to 1.4 million.

GM has linked the defect to 31 crashes involving airbags that failed to deploy and the deaths of 13 motorists.
Depositions taken during a civil lawsuit against GM revealed the auto maker knew in 2004, a decade before it issued a recall, that its Chevrolet Cobalt had an ignition switch that could inadvertently shut off the engine while driving.

According to news reports Tuesday, the U.S. Attorney's Office in New York has opened a criminal probe into the circumstances surrounding the GM ignition switch recall.

We would like to talk to you about any cases involving serious injuries or deaths resulting from crashes involving the 2005-2007 Chevy Cobalt, or model year 2003-2007 Pontiac G5, Saturn Ion, Chevy HHR, Pontiac Solstice and Saturn Sky.

The process of demanding compensation for the harm you’ve suffered can be complicated, even if it doesn’t seem fair that you should have to go through even more trouble to be made whole again.

We believe that obtaining legal satisfaction from those who harmed you shouldn’t require more hardship. That’s why we do everything we can to streamline the process, and we will file a lawsuit on your behalf if necessary. If you or a loved one has been affected by this recall, and you believe it caused an injury, contact Chhabra & Gibbs today by going to http://www.cglawms.com or calling this number: 601-948-8005.

Tuesday, February 25, 2014

Testosterone Product Injuries

The U.S. Food and Drug Administration (FDA) is advising the public that it is evaluating studies showing that prescription testosterone products might cause stroke, heart attacks, and death in men who use them.

What Are Testosterone Products and What Are They Prescribed For?

Testosterone is a hormone that plays a major role in promoting masculine traits and men’s health. The FDA approves testosterone replacement drugs for men who lack the hormone due only to a medical condition, such as chemotherapy, failure or the testicles to produce testosterone due to a genetic defect, or neurological problems that interfere with testosterone production.
Prescription testosterone products deliver the hormone through various mechanisms: topical gels; transdermal patches; buccal products (applied to the inner cheek); and injections.

Testosterone Products Might Cause Heart-Related Side Effects

In late January 2014, the FDA issued a drug safety communication stating that it was continuing its evaluation of the safety of testosterone products after two studies were published indicating that they were more dangerous than previously recognized. The FDA did not change its position one way or another on the safety of testosterone products, just that it would take the new studies’ findings into account.

The first study appeared in the Journal of the American Medical Association in November 2013. The researchers studied a group of men in the U.S. Veterans Affairs health system that had low testosterone levels and were undergoing cardiac tests. Some of the men were receiving testosterone treatment while others were not. The men were about 60 years old on average. The study found that recipients of testosterone products were 30 percent more likely to suffer stroke, heart attack, or death.

The second study was published in PLOS One in January 2014, and it compared the health outcomes of more than 55,000 men who filled prescriptions for testosterone products to their health in the previous year. The authors found that men over the age of 65 who filled testosterone products prescriptions were twice as likely to suffer a heart attack within the next 90 days. Younger men who had a history of heart problems had a double or triple risk of heart attack 90 days after the testosterone products prescriptions were filled. Younger men had no discernible increased risk of heart attacks.

Even though the FDA has not formally determined that testosterone products are unsafe, it is still possible for injured men and their families to hold the manufacturers accountable legally.
Chhabra & Gibbs Will Make Things Easier


The process of demanding compensation for the harm you’ve suffered can be complicated, even if it doesn’t seem fair that you should have to go through even more trouble to be made whole again.                

We believe that obtaining legal satisfaction from those who harmed you shouldn’t require more hardship. That’s why we do everything we can to streamline the process, and we will file a lawsuit on your behalf if necessary. If you or a loved one has used a testosterone product, and you believe it caused an injury, contact Chhabra & Gibbs today by going to http://www.cglawms.com or calling this number: 601-948-8005.

Monday, February 24, 2014

Lipitor Diabetes Lawsuits

In early 2012, analysis of clinical trial results prompted the U.S. Food and Drug Administration (FDA) to change the labels of the cholesterol-reducing drug Lipitor to state that it increases a user’s risk of developing type-2 diabetes.

Patients who have taken Lipitor and developed type-2 diabetes have filed lawsuits against Pfizer, Lipitor’s manufacturer, for injuries caused by Lipitor’s potential side effects. These lawsuits are currently pending in courthouses throughout the country. Many of them allege that, way before 2012, Pfizer was aware of—but nevertheless failed to warn customers about—Lipitor’s propensity to increase serum glucose levels.

Chhabra & Gibbs Will Make Things Easier

Have you developed type-2 diabetes or some other harmful condition as a result of having taken Lipitor? If so, contact Chhabra & Gibbs by going to http://www.cglawms.com or calling this number:601-948-8005
We believe that obtaining legal satisfaction from those who harmed you shouldn’t require more hardship. That’s why we do everything we can to streamline the process, and we will file a Lipitor lawsuit on your behalf if necessary.

If you have taken Lipitor and believe it harmed you, contact Chhabra & Gibbs today.

Friday, February 21, 2014

Transvaginal Mesh Pelvic Cavity Tearing Lawsuit


Thousands of women who have received transvaginal mesh implants to treat stress urinary incontinence (SUI) or pelvic organ prolapse (POP) have filed lawsuits in state and federal court to recover compensation for the debilitating injuries they suffered from the transtvaginal mesh products.

If you received a transvaginal mesh implant and were injured as a result, you might be eligible for compensation from the mesh’s manufacturer—whether or not the particular brand of transvaginal mesh your doctor used has been recalled, or is still on the market.

Transvaginal Mesh Victims Are Recovering Compensation

A victim of injuries from transvaginal mesh manufactured by C.R. Bard recovered $5.5 million in 2012 after her case was tried in California state court, and a victim of injuries resulting from transvaginal mesh manufactured by Johnson & Johnson’s Ethicon unit recovered more than $7 million in 2013 after her case was tried in New Jersey state court.

Most recently, in August 2013, the jury in the first trial of one of the thousands of cases against C.R. Bard pending in West Virginia ordered C.R. Bard to pay $250,000 in compensatory damages and $1.75 million in punitive damages. In that case, Donna Cisson, a public-health nurse from Georgia, allegedly stated that Bard’s Avaulta mesh product, which she was implanted with in 2009, caused her to suffer serious pain and injury, and that she underwent several surgeries to have it removed. Under Georgia law, 75 percent of the $1.75 million punitive-damages award was handed over to the state’s general fund, so, between punitive and compensatory damages, Cisson walked away with about $600,000.

Transvaginal mesh victims have also recovered settlement awards (that is, compensation that resulted from negotiations with the mesh manufacturers’ lawyers, not from a jury’s decision). In late June 2013, Endo Health Solutions announced that it will pay $55 million to settle an undisclosed number of lawsuits filed by women who claim they suffered serious injuries from transvaginal mesh products manufactured by the company’s American Medical Systems unit (AMS).

Thousands of Transvaginal Mesh Cases Are Still Patent Pending

ll federal-level transvaginal mesh lawsuits that are still pending against five mesh manufacturers have been consolidated into five multidistrict litigation (MDL) proceedings in the U.S. District Court for the Southern District of West Virginia. District Court Judge Joseph Goodwin is the presiding judge. The five companies involved are: C.R. Bard; American Medical Systems; Boston Scientific; Ethicon; and Cook Medical.

MDL allows parties whose cases share common opponents, facts, and legal issues to combine their cases for the pretrial phase only. Consolidation saves the parties’ and the judiciary’s time and resources while allowing plaintiffs the opportunity to recover an amount of compensation that corresponds to their injuries, unlike in a class action lawsuit, which provides a fixed award.

At the end of the pretrial process, the parties select a handful of plaintiffs, whose cases are typical of all plaintiffs, to try their cases before juries in what are called “bellwether trials.” The first transvaginal mesh bellwether against C.R. Bard was scheduled in July 2013.

There are also lawsuits for transvaginal mesh injuries pending in several state courts around the country.

Chhabra & Gibbs Can Help Women Injured by Transvaginal Mesh


The recent jury awards and settlement amounts received by transvaginal mesh victims are proof that perseverance, plus compassionate representation by a qualified attorney, can lead to victory against faulty medical device manufacturers.

If you or someone you know has had surgery for that involved the implantation of surgical mesh, and is experiencing symptoms consistent with malfunction, contact Chhabra & Gibbs by going to our website at http://www.cglawms.com/ or calling this number: 601-948-8005. 

Thursday, February 20, 2014

Jury Links Commonly Used Talc Powder To Ovarian Cancer

A federal jury has found that talcum contained in Johnson & Johnson powder products contributed to a woman’s ovarian cancer.  The jury found on that Johnson & Johnson failed to warn consumers of the link between ovarian cancer and the use of talc-based body powder for feminine hygiene.
Deane Berg, a resident of Sioux Falls, who was diagnosed with ovarian cancer in 2006, filed the lawsuit. The 56-year-old berg used talcum-based products for hygiene purposes for about 30 years, including J&J’s shower to shower body powder.
Attorney R. Allen Smith, Jr., one of Berg’s lawyers, said his client never would have used the products in the manner she did if she had seen a warning.  “The first time she heard about the risk was after her diagnosis,” Smith said.  Smith of Ridgeland, Mississippi, filed the very first talcum ovarian cancer lawsuit in 2009.
The verdict comes shortly after the Mississippi Attorney General’s office launched an investigation into Johnson & Johnson’s promotion of talcum powder products used for feminine hygiene.
The jury did not award Berg monetary damages nor did it agree that Johnson & Johnson’s products are defective without a warning label
Medical Studies Link Talcum Powder to Cancer Risk
A recent study conducted by Dr. Margaret A. Gates and funded by the National Cancer Institute and the National Institutes of Health, focused on talc ovarian cancer, found a 36-41% increase in ovarian cancer related to use of talc.  The study advised women to immediately stop using the product.
A June report published in the medical journal cancer prevention research, and based on data collected covering about 2,000 women, found that women who use powder containing talc may have a 20% to 30% greater risk of ovarian cancer.
Medical Experts Testify

Mr. Smith is working with the two of the foremost medical experts on the subject of talc and ovarian cancer (Daniel Cramer, MD and John Godieski, MD).  Dr. Cramer, who has studied the connection between talc and cancer for 30 years told jurors that talc probably was a contributing factor in 10,000 cases of ovarian cancer each year.
Doctors analyzed berg’s cancer tissue, found talc using a scanning electron microscope and concluded that body powder was the cause.
Attorneys To Expand Talc Related Cancer Investigation

This talcum powder lawsuit may be first of many other talc related cancer lawsuits that are to be investigated and filed by attorney Smith and his associated group, the Talc Litigation Group.


Talc Products Affected
Numerous other talc products are impacted by the lawsuit;
•Johnson’s ® baby powder
•Shower to Shower® absorbent body powder
•and all other talcum powder products.

What Do I Do If I Think I May Have Been Injured?
Regardless of where you live, contact Chhabra & Gibbs P.A. by going to http://www.cglawms.com or calling this number: 601-948-8005


Friday, January 10, 2014

BP Oil-Spill Settlement Approval Upheld by Appeals Court

Approval of BP Plc (BP/)’s $9.2 billion partial settlement of private-party claims from the 2010 Gulf of Mexico oil spill was upheld by a U.S. appeals court.
Objectors said the settlement was unfair and couldn’t be approved because it inconsistently compensated victims with the same types of economic injuries. London-based BP asked the court to delay approval until a dispute over the payment of claims is resolved in the company’s favor.
The U.S. Court of Appeals in New Orleans today upheld U.S. District Judge Carl Barbier’s December 2012 endorsement of the accord.
“We cannot agree with the arguments raised by the objectors or BP,” U.S. Circuit Judge W. Eugene Davis said today in a 2-1 ruling. “Neither class certification nor settlement approval are contrary” to federal law, the court said.
The April 2010 Macondo well blowout and the explosion that followed killed 11 workers and set off the worst offshore oil spill in U.S. history. The sinking of Transocean Ltd. (RIG)’s Deepwater Horizon drilling rig and the spill led to hundreds of lawsuits against BP and its partners and contractors.
The company settled with most private plaintiffs in March 2012, just before a non-jury trial was to begin on liability for the incident and on whether BP or its contractors, Halliburton Co. (HAL) and Transocean, acted with gross negligence.
Loss Claims
The accord resolved economic-loss claims for multiple classes of businesses and property owners in Louisiana, Alabama and Mississippi and in parts of Texas and Florida. It excluded claims of financial institutions, casinos, private plaintiffs in parts of Florida and Texas, and residents and businesses claiming harm from the Obama administration’s moratorium on deep-water drilling prompted by the spill. It also didn’t cover claims by governments.
BP initially valued the economic-loss settlement at $7.8 billion. It later revised that estimate to $9.2 billion, according to an Oct. 29 company regulatory filing.
Barbier gave final approval to the settlement in December 2012, certifying the case as a class action, or group lawsuit. Multiple groups of plaintiffs subsequently appealed, contending it couldn’t be a class action because all victims weren’t treated the same.
The case is In re Deepwater Horizon-Appeals of the Economic and Property Damage Class Action Settlement, 13-30095, U.S. Court of Appeals for the Fifth Circuit (New Orleans).
The lower-court case is In re Oil Spill by the Oil Rig Deepwater Horizon in the Gulf of Mexico on April 20, 2010, 10-md-02179, U.S. District Court, Eastern District of Louisiana (New Orleans).